PHARMACOKINETIC PARAMETERS | FLBZ | R-FLBZ | ||||
---|---|---|---|---|---|---|
FLBZ-CDs(1)i.r. treatment | FLBZ-CMC(1)i.r. treatment | FLBZ-CDs(2)i.a. treatment | FLBZ-CDs(1)i.r. treatment | FLBZ-CMC(1)i.r. treatment | FLBZ-CDs(2)i.a. treatment | |
T½abs/for (h) | 3.67 ± 1.57 | 2.92 ± 0.94 | 0.40 ± 1.43* | 3.00 ±1.21 | 4.95 ± 1.72 | 0.90 ± 0.30* |
Cmax (μg/mL) | 0.05 ± 0.01 | 0.03 ± 0.01 | 0.07 ± 0.04* | 0.23 ± 0.04 | 0.14 ± 0.03* | 0.35 ± 0.09* |
Tmax (h) | 12.0 ± 3.79 | 12.5 ± 2.95 | 2.75 ± 2.36* | 10.5 ± 4.93 | 11.5 ± 1.22 | 2.75 ± 1.50* |
AUC0-t (μg.h/mL) | 1.35 ± 0.34 | 0.78 ± 0.53 | 0.65 ± 0.29 | 6.82 ± 1.77 | 4.92 ± 1.46 | 3.83 ± 1.86* |
T½el (h) | 25.8 ± 14.0 | 19.2 ± 15.1 | 15.1 ± 8.27* | 17.0 ± 5.19 | 18.4 ± 3.74 | 6.73 ± 3.70* |
MRT (h) | 41.6 ± 19.0 | 34.5 ± 20.3 | 19.7 ± 9.73* | 28.8 ± 8.58 | 35.4 ± 3.90 | 10.8 ± 4.07* |